Please try another search
BIO-UV Group S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 51.29 million compared to EUR 33.46 million a year ago. Net income was EUR 2.42 million compared to EUR 0.689376 million a year ago. Basic earnings per share from continuing operations was EUR 0.238 compared to EUR 0.068 a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 10.23 | 10.23 | 15.41 | 15.41 |
Gross Profit | 9.22 | 9.22 | 4.86 | 4.86 |
Operating Income | 0.383 | 0.383 | 1.68 | 1.68 |
Net Income | 0.053 | 0.053 | 1.16 | 1.16 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 74.1 | 74.1 | 80.52 | 80.52 |
Total Liabilities | 41.74 | 41.74 | 48.35 | 48.35 |
Total Equity | 32.35 | 32.35 | 32.17 | 32.17 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 0.396 | 0.396 | 0.953 | 0.953 |
Cash From Investing Activities | -0.725 | -0.725 | -3.75 | -3.75 |
Cash From Financing Activities | 0.092 | 0.092 | -1.34 | -1.34 |
Net Change in Cash | -0.254 | -0.254 | -4.16 | -4.16 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review